# C_2020278EN.01000401.xml

| 24.8.2020 | EN | Official Journal of the European Union | C 278/4 |
| --- | --- | --- | --- |

24.8.2020

EN

Official Journal of the European Union

C 278/4

---

Prior notification of a concentration

(Case M.9876 – TA Associates/Francisco Partners/Edifecs)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 278/04)

1.

This notification concerns the following undertakings:

| — | funds managed by TA Associates Management L.P. (‘TA Associates’, United States), |
| --- | --- |

—

funds managed by TA Associates Management L.P. (‘TA Associates’, United States),

| — | funds managed by Francisco Partners Management LP (‘Francisco Partners’, United States), |
| --- | --- |

—

funds managed by Francisco Partners Management LP (‘Francisco Partners’, United States),

| — | Edifecs, Inc. (‘Edifecs’, United States). |
| --- | --- |

—

Edifecs, Inc. (‘Edifecs’, United States).

TA Associates and Francisco Partners acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control over Edifecs.

The concentration is accomplished by way of purchase of shares.

2.

| — | for TA Associates: private equity firm, active in investing in five core sectors, namely technology, financial services, healthcare, consumer and business services industries in Europe, North America and Asia, |
| --- | --- |

—

for TA Associates: private equity firm, active in investing in five core sectors, namely technology, financial services, healthcare, consumer and business services industries in Europe, North America and Asia,

| — | for Francisco Partners: private equity firm exclusively focused on investment in technology and technology-enabled businesses, |
| --- | --- |

—

for Francisco Partners: private equity firm exclusively focused on investment in technology and technology-enabled businesses,

| — | for Edifecs: healthcare technology company active in the provision of infrastructure solutions which aim to improve operational performance by streamlining the exchange of information between hospitals and other healthcare organisations, while enabling compliance with industry regulations. |
| --- | --- |

—

for Edifecs: healthcare technology company active in the provision of infrastructure solutions which aim to improve operational performance by streamlining the exchange of information between hospitals and other healthcare organisations, while enabling compliance with industry regulations.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9876 – TA Associates/Francisco Partners/Edifecs

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---